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Abstract
Background
Evidence of an association between serum vitamin D and cardiovascular disease risk is in-
consistent and comes predominantly from studies in high-income settings. We assessed
the association between serum levels of 25-hydroxyvitamin D3 (25(OH)D) and cardiovascu-
lar disease risk factors in a population of young Indian adults.
Methods
Cross-sectional analyses of data from APCAPS (Andhra Pradesh Children and Parents
Study); a prospective birth cohort study in rural south India. Participants were 1038 (40.3%
females) adults aged 18-24 years. Main outcome measures were blood pressures, fasting
serum lipids (cholesterols and triglycerides), fasting glucose, insulin, measures of arterial
stiffness (aortic augmentation index and aortic pulse wave velocity (aPWV)), carotid intima-
media thickness, body mass index (BMI) and body fat (dual X-ray absorptiometry).
Results
Vitamin D deficiency (20ng/ml) was observed in 41.1% of this lean (mean BMI: 19.5) and
active (mean minutes of moderate or vigorous physical activity per day: 186) population. Vi-
tamin D deficiency was associated with higher median body fat in both males (15.9% body
fat in vitamin D deficient males vs. 14.6% in non-deficient males, p<0.05) and females
(29.1% body fat in vitamin D deficient females vs. 27.8% in non-deficient females, p<0.05)
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but no associations were observed between vitamin D deficiency and mean BMI or median
fat mass index (FMI). Except a weak inverse association with fasting insulin in males, there
was no clear association between serum vitamin D levels and cardiovascular disease risk
factors in fully adjusted models.
Conclusions
We did not find clear evidence for an association between serum vitamin D levels and car-
diovascular disease risk factors. Our results, consistent with the limited evidence from ran-
domised trials of vitamin D supplementation and Mendelian randomisation experiments,
suggest that the postulated link between serum vitamin D and cardiovascular disease may
be non-causal. Instead, it may be attributable to confounding by lifestyle factors such as
obesity and physical inactivity which may provide more fruitful targets for cardiovascular
disease prevention.
Introduction
Systematic reviews of observational studies have reported inverse associations between serum
vitamin D levels and a range of cardiovascular disease risk factors, most notably hypertension,
but also dyslipidaemia, abnormal glucose homeostasis and atherosclerosis [1–6]. However, the
few randomised trials of vitamin D supplementation completed to date have failed to show a
clear beneficial effect on cardiovascular events, raising questions about the causal role of vita-
min D in cardiovascular disease (CVD) [7, 8].
Observational studies examining the association between vitamin D levels and CVD risk
have predominantly been conducted in high-income countries, where the perceived rise in the
prevalence of vitamin D deficiency has taken place alongside a rise in the prevalence of obesity
and physical inactivity[8]. Obesity and physical inactivity are both independent risk factors of
CVD and are also associated with lower levels of vitamin D, thus suggesting a non-causal ex-
planation for their association [9]. The hypothesis that observational evidence for an associa-
tion between vitamin D and cardiovascular risk may be confounded is partially supported by
evidence from Mendelian Randomisation (MR) studies. These studies, which have found no
clear association between genetic markers of vitamin D and cardiovascular risk or cardiovascu-
lar mortality, provide evidence of a causal association between genetic markers of obesity and
circulating vitamin D levels [10–13].
Some observational studies have tried to control for obesity when assessing the relationship
between vitamin D and CVD, using body mass index (BMI) as a proxy, and found inconsistent
results; however, BMI is non-specific and residual confounding cannot be ruled out [14, 15]. A
more robust approach to control for imprecisely measured confounders, like obesity and physi-
cal inactivity, is to conduct the study in a population with an absent or extremely low preva-
lence of the putative confounder. We examined a lean population of young adults from rural
South India in order to study the relationship between 25(OH)D and a comprehensive range of
cardiovascular risk factors. The availability of data on body fat assessed by Dual energy X-ray
Absorptiometry (DXA) and physical activity, lacking in many previous studies, further allowed
us to reliably assess the potential confounding role of these key risk factors of CVD.
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Methods
Study Design and Population
The Andhra Pradesh Children and Parents Study (APCAPS) is a prospective cohort study con-
ducted in 29 villages near Hyderabad city in South India. It was established through the long-
term follow-up of family members of participants of the Hyderabad Nutrition Trial (HNT)
(1987–1990), in which supplemental nutrition was offered to pregnant women and young chil-
dren from a block of 15 villages (an intervention arm) [16, 17]. We conducted cross-sectional
analysis of data from the second wave of this study when serum vitamin D and cardiovascular
risk factors were assessed in the index trial children (those born between 1987 and 1990 and re-
liably linked during initial follow up in 2003–5).
Ethics Statement
The study received approval from the ethics committees of the National Institute of Nutrition
(NIN) (Hyderabad, India) and London School of Hygiene and Tropical Medicine (London,
UK). Approval was also sought from the Indian Council for Medical Research and the village
heads and their committees in each of the study villages. Written informed consent or wit-
nessed thumbprint if illiterate was obtained from the participants prior to their inclusion in
the study.
Measurements
The study participants were interviewed and examined by trained interviewers at the National
Institute of Nutrition (NIN) in Hyderabad between 2009 and 2010.
Questionnaire data. Socio-demographic and lifestyle information was collected through
a structured questionnaire. Socio-economic status was measured with a subset of questions
(14/29) from the Standard of Living Index (SLI), a household level asset-based scale devised for
Indian settings [18].
Physical activity undertaken in the week preceding the clinic was assessed using a question-
naire developed and evaluated previously in a similar setting [19]. The frequency of and aver-
age length of time spent on activities were documented for multiple domains, including work,
travel, leisure (sports/games/exercise), household chores, and time spent being sedentary.
Physical examination. Height was measured to the nearest 1mm with a portable plastic
stadiometer (Leicester height measure; Chasmors, London) and weight was measured to the
nearest 0.1kg with a digital SECA balance. Each measure was taken twice and the average was
used for analysis.
Lean mass and fat mass were measured with Dual energy X-Ray Absorptiometry (DXA).
95% of scans were performed on a Hologic Discovery A model and 5% on a Hologic 4500W.
The same software version was used on both machines. The whole body scan was performed
with participants supine on the scanning bed. Women suspected of pregnancy (n = 22) were
excluded from DXA scanning. Standard Hologic software options were used to define regions
of the body (head, arms, trunk, and legs). Scans were coded for artefacts by visual inspection;
incomplete scans and those with major movement were excluded. DXA abdominal fat mea-
sures showed excellent agreement with abdominal adipose tissue measured by magnetic reso-
nance imaging (MRI) in a subset of the study population [20]. Fat mass index, considered to be
a more valid measure of body composition[21], was calculated as body fat mass (kg) / height
(m)2 and lean mass index (LMI) was calculated as lean mass (kg) / height (m)2.
Systolic and diastolic blood pressure was measured with a validated oscillometric device
(Omron M5-I, Matsusaka Co., Japan) in the supine position, with appropriate cuff sizes. Each
Vitamin D and Cardiovascular Risk
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measure was taken three times and the average of the second and third reading was used
for analysis.
Carotid intima-media thickness was measured on the right-hand side near wall of the distal
common carotid artery using ultrasound. Images were analysed using Carotid Plaque Texture
Analysis software (LifeQ, Engomi, Cyprus). Images were first normalised to enable reproduc-
ibility of texture features and plaque types. Where more than one image was available for a par-
ticipant an average of all image readings was used for analysis.
Aortic augmentation index, a measure of arterial wave reflections, was measured by appla-
nation tonometry on the radial artery using the SphygmoCor device (AtCor Medical Pty Ltd,
West Ryde, Australia). If the first two readings were not within 5% points of each other, a third
was taken. The mean of the two closest readings was used for analysis. Aortic pulse wave veloc-
ity, a measure of arterial stiffness, was determined using the Vicorder device (Skidmore Medi-
cal, Bristol, UK). Blood pressure cuffs were placed around the upper thigh and around the neck
at the level of the carotid artery to measure femoral and carotid pulses. The cuffs were then in-
flated to 60mmHg and waveforms recorded using a volume displacement method [22].
Laboratory assessment of blood samples. Participants attended morning clinics and were
asked to fast overnight. The time of their last meal was recorded. Venous blood samples
(20mL) were collected. All assays, except for fasting glucose and serum vitamin D (which were
measured at NIN), were performed in the Genetics and Biochemistry Laboratory of the South
Asia Network for Chronic Disease, New Delhi. 25(OH)D was measured using a high-
performance liquid chromatography (HPLC) method and detected at 265nm using an ultravio-
let detector (CV: 7%). Serum High-Density Lipoprotein cholesterol (HDL) was estimated di-
rectly by an elimination method, total cholesterol by an enzymatic endpoint method, and
triglycerides by GPO-PAP method. Low-Density Lipoprotein cholesterol (LDL) was calculated
using the Friedewald formula (total cholesterol—HDL cholesterol—triglycerides) [23]. Insulin
was measured with the enzyme-linked immunosorbent assay (ELISA) method, using solid
phase, two-site enzyme immunoassay (MERCODIA, Uppsala, Sweden). Fasting glucose was
measured using an oxidase-peroxidase system [24].
The quality of assays was checked with regular external standards and internal duplicate as-
says and monitored by All India Institute of Medical Sciences (AIIMS). The Cardiac Biochem-
istry Lab, AIIMS, is part of the UK National External Quality Assessment (www.ukneqas.org.
uk) programme and External Quality Assessment Scheme from RANDOX for quality assur-
ance of insulin and biochemical assays respectively.
Statistical Analysis. Socio-demographic and biological characteristics of the study sample
were compared by vitamin D status. Normally distributed continuous variables were reported
as means (± standard deviation) and skewed continuous variables were reported as medians
(with interquartile range). Comparison of means and medians used unpaired t-tests and
Mann-Whitney tests respectively. Chi-squared tests were used to compare categorical
variables.
Exploratory analysis highlighted linear relationships between 25(OH)D and most CVD out-
comes. The exposure variable (25(OH)D) and two outcome variables (triglycerides and insu-
lin) were log-transformed to achieve a distribution closer to normal.
Associations between 25(OH)D and cardiovascular risk factors were examined using linear
mixed-effects regression models. To account for possible clustering of exposures, robust stan-
dard errors were applied at the household and village levels. Two models, stratified by sex,
were fitted and adjusted for potential confounders or intermediaries: model 1—age and inter-
vention status; model 2—as in model 1, plus SLI, occupation, smoking status, time spent in
moderate or vigorous physical activity, and body fat. Analysis of 25(OH)D level by month
of test suggested that the season in which the clinical examination took place influenced levels
Vitamin D and Cardiovascular Risk
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of serum vitamin D. Month of test was therefore also included as possible confounder in
model 2.
All statistical analysis was carried out using Stata version 13 (StataCorp, College Station,
Texas).
Results
All 2581 living members of the Hyderabad Nutrition Trial cohort (born between 1987 and
1990) were invited to participate; 1446 (56%) attended. Attendees were more likely to be male
than were non-attendees (68% vs 28%). Due to machine malfunction, assessment of 25(OH)D
was conducted on blood samples of 1038 (72%) participants. Those without 25(OH)D data
were more likely to be male as compared to those with (89% vs 60%), but comparisons of life-
style characteristics illustrated similarities between groups (Table 1). After excluding those who
did not fast overnight (n = 36) 1002 participants were left for analysis of fasting glucose, insu-
lin, HDL and LDL.
Table 2 shows the distribution of characteristics for the study sample by vitamin D status.
The mean age of the sample was 21 (SD: 1.1) and the mean BMI was 19.5 (SD: 2.9). Forty one
percent (52% of females, 34% of males) of the participants were vitamin D deficient (25(OH)
D20ng/ml [25]). Participants with vitamin D deficiency had higher levels of % body fat, but
did not have higher BMI or FMI, as compared to those without deficiency. Males with vitamin
D deficiency were less physically active compared to non-deficient males, but no such differ-
ence was noted in females.
Although we saw a weak inverse association with fasting serum insulin (in males only),
there were no consistent associations between 25(OH)D and other CVD risk factors in unad-
justed or fully adjusted models (Table 3 for males and Table 4 for females). The association be-
tween 25(OH)D and fasting insulin was not attenuated on adjustment for body fat, despite the
association between insulin and body fat. We explored the possibility of effect modification of
this association by body fat, but found no strong evidence for this (P interaction = 0.19). Re-
garding physiological CVD risk factors, % body fat displayed a strong inverse association with
serum vitamin D in both sexes but for FMI a similar association was only observed in females.
Diastolic blood pressure appeared to have a small inverse association with vitamin D in fe-
males, but this attenuated after adjustment.
Discussion
In this community-based sample of lean and active young adults from rural India we found no
clear association between serum vitamin D levels and CVD risk factors, including blood
Table 1. Key characteristics of APCAPS participants with a serum vitamin D result (n = 1038) compared to APCAPS participants without a serum
vitamin D result (n = 408); 2009–10.
Males Females
With a serum vitamin
D result (n = 620)
Without a serum vitamin
D result (n = 361)
p-value With a serum vitamin
D result (n = 418)
Without a serum vitamin
D result (n = 47)
p-value
Age (years) 20.99 20.43 <0.001 21.01 20.93 0.63
Body Mass Index (kg/m2) 19.76 19.63 0.49 19.12 19.19 0.87
Body fat (%) 15.95 15.2 0.02 28.35 27.5 0.33
Standard of Living Index 36.68 36.67 0.84 34.73 34.55 0.89
Values are means. P-values are based on unpaired t-tests for heterogeneity in means, with appropriate degrees of freedom
doi:10.1371/journal.pone.0129468.t001
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Table 2. Distribution of socio-demographic and biological characteristics of APCAPS participants (n = 1038), 2009–10.
Males (n = 620) Females (n = 418)
n Vitamin D Deﬁcient*
(n = 211)
Vitamin D non-
Deﬁcient (n = 409)
p-value† n Vitamin D Deﬁcient*
(n = 216)
Vitamin D non-
Deﬁcient (n = 202)
p-value†
Socio-demographics
Age (years) 620 21.1(1.1) 20.9(1.1) 0.16 418 21.0(1.2) 21.0(1.2) 0.56
Standard of Living Index 614 18.6(4.2) 18.7(4.1) 0.91 415 18.1(4.4) 17.1(4.5) 0.02
Occupation (%)¶ 619 0.55 418 0.09
At home/ unemployed 3.8 2.9 33.8 41.6
Student 39.3 35.1 35.2 24.8
Manual 52.1 55.4 27.8 31.7
Professional 4.7 6.6 3.2 2.0
Smoking (%)§ 619 <0.01 417 -
Never 93.4 83.6 100 100
Former/Current 6.6 16.4 0 0
MVPA Time (mins/day)‡ 620 176.0(106.4 to 265.7) 201.4(122.3 to 311.0) 0.05 418 68.4(35.6 to 117.8) 71.1(32.4 to 162.9) 0.87
Biological characteristics
Body Mass Index (kg/m2) 619 19.75(2.66) 19.76(2.82) 0.95 418 19.12(3.1) 19.11(2.78) 0.99
Body Fat (%)‡ 620 15.9(12.9 to 19.4) 14.6(11.8 to 18.9) 0.02 380 29.1(25 to 33) 27.8(23.9 to 31.7) 0.04
Fat Mass Index (body fat
kg/ m2) ‡
619 3.03(2.29 to 4.11) 2.71(2.14 to 3.83) 0.06 380 5.32(4.31 to 6.71) 5.01(4.11 to 6.30) 0.21
Lean Mass Index (lean
mass kg/ m2)
619 15.6(1.6) 15.7(1.6) 0.54 381 12.7(1.7) 12.9(1.3) 0.24
Systolic blood pressure
(mmHg)
620 117.1(9.5) 117.6(9.0) 0.55 418 109.9(10.0) 108.6(8.3) 0.15
Diastolic blood pressure
(mmHg)
620 70.4(8.4) 70.1(7.5) 0.59 418 69.0(8.7) 67.8(7.4) 0.15
Carotid IMT (mm) 601 0.6(0.1) 0.6(0.1) 0.83 407 0.5(0.1) 0.5(0.1) 0.40
Aortic Augmentation Index
(%)
615 2.7(10.0) 1.5(11.2) 0.20 408 3.4(13.4) 2.2(12.1) 0.33
Aortic Pulse Wave
Velocity (m s-1)
620 5.97(0.04) 5.99(0.03) 0.71 409 5.81(0.04) 5.74(0.04) 0.25
Insulin (mU/L)‡ ф 601 3.8(2.8 to 5.2) 3.8(2.8 to 5.1) 0.91 401 4.1(2.9 to 5.8) 3.6(2.4 to 5.2) 0.02
Fasting glucose (mmol/L) ф 601 4.8(0.5) 4.8(0.5) 0.13 401 4.8(0.4) 4.8(1.0) 0.94
Triglycerides (mg/dl)‡ 620 86(70 to 110) 94(74 to 118) 0.02 418 83(65 to 107.5) 85.5(68 to 117) 0.09
Total cholesterol (mmol/L) 620 4.00(0.93) 4.03(0.9) 0.76 418 3.98(0.85) 4.07(0.9) 0.31
HDL cholesterol (mmol/L)
ф
601 1.0(0.2) 1.0(0.2) 0.74 401 1.1(0.2) 1.1(0.2) 0.49
LDL cholesterol (mmol/L) ф 598 2.5(0.9) 2.5(0.8) 0.60 401 2.4(0.7) 2.5(0.7) 0.97
25(OH)D (ng/ml)‡ 620 15.2(12.1 to 17.7) 29(24.5 to 35.9) - 418 15(11.7 to 17.6) 24.25(22.2 to 29) -
All values are means(SD) unless otherwise stated.
MVPA = Moderate or Vigorous Physical Activity; 25(OH)D = 25-hydroxyvitamin D3, IMT = Intima-Media Thickness, HDL = High-density lipoprotein,
LDL = Low-density lipoprotein
* We used a cut-off of 20ng/ml to deﬁne deﬁciency (equal to 50nmol/l) [18].
† p-values are based on unpaired t-tests for heterogeneity in means, with appropriate degrees of freedom.
‡ non-normal distribution; median (inter-quartile range) presented, and p-values are based on Mann-Whitney rank-sum tests for equality.
Ф Analysis of fasting glucose, insulin, HDL cholesterol and LDL cholesterol exclude participants who did not fast (n = 36)
§ Smoking status; former user = ceased use >6 months ago; current user = used in the last 6 months.
¶ Manual occupations include roles such as labourers, craftsmen, servants, postal staff and farmers; professional occupations include role such as
teachers, accountants, clinicians, business owners and engineers.
doi:10.1371/journal.pone.0129468.t002
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pressures, arterial stiffness, carotid intima-media thickness and fasting lipids, glucose and insu-
lin. Serum vitamin D was inversely associated with DXA-assessed body fat percentage in both
sexes and with FMI in females only, but no relationship was observed between serum vitamin
D and BMI.
Comparison with previous research
The high prevalence of vitamin D deficiency (41%) in our study was similar to estimates from
other studies of healthy populations in India and other settings [26–30]. The lack of any robust
associations between 25(OH)D and a range of CVD risk factors in our study contradicts find-
ings from existing observational studies [4, 7]. However, this is in line with limited evidence
from intervention studies of vitamin D supplementation and MR experiments using genetic
markers of vitamin D deficiency, which have also failed to detect any clear associations between
the two.
As expected, BMI, and DXA-assessed % body fat and FMI were all strongly correlated.
However, these three measures did not display similar associations with serum vitamin D. Our
finding of an association between serum vitamin D and DXA-assessed body fat in both sexes,
and FMI in females, partly supports our hypothesis that the reported association between vita-
min D levels and CVD risk, despite adjustment for BMI, may reflect residual confounding
Table 3. Association of serum vitamin D (25(OH)D)†with cardiovascular risk factors in a sample of young Indianmales from the Andhra Pradesh
Children and Parents Study (n = 620)Ф; 2009–10.
Model 1 Model 2
n β coefﬁcient(95% CI) p N β coefﬁcient(95% CI) P
Outcomes—Physiological
Body Mass Index (kg/m2)* 619 0.07(-0.43 to 0.57) 0.77 613 0.00(-0.50 to 0.51) 1.00
Body Fat by DXA (%)* 620 -0.06(-0.11 to -0.00) 0.03 614 -0.05(-0.1 to 0.00) 0.06
Fat Mass Index (body fat kg/ m2)* 619 -0.05(-0.12 to 0.02) 0.15 613 -0.05(-0.13 to0.02) 0.16
Systolic BP (mmHg) 620 -0.05(-1.68 to 1.58) 0.95 614 0.55(-1.10 to 2.20) 0.52
Diastolic BP (mmHg) 620 -0.60(-1.98 to 0.77) 0.39 614 -0.06(-1.39 to 1.27) 0.93
Carotid IMT (mm) 601 0.01(-0.01 to 0.03) 0.43 595 0.00(-0.02 to 0.02) 0.89
Aortic Augmentation Index (%) 615 -0.58(-2.51 to 1.35) 0.56 609 -0.93(-2.81 to 0.96) 0.33
aPWV (m s-1) 620 -0.00(-0.11 to 0.11) 0.94 614 0.01(-0.10 to 0.12) 0.82
Outcomes—Biochemical
Insulin (mU/L)† 599 -0.11(-0.21 to -0.02) 0.02 593 -0.12(-0.21 to -0.02) 0.01
Fasting Glucose (mmol/L) 601 -0.07(-0.16 to 0.02) 0.14 595 -0.09(-0.18 to 0.01) 0.08
Triglycerides (mg/dl)† 620 0.02(-0.04 to 0.09) 0.50 614 0.03(-0.03 to 0.09) 0.89
Cholesterol (mmol/L) 620 0.07(-0.10 to 0.23) 0.42 614 0.16(0.00 to 0.31) 0.05
HDL Cholesterol (mmol/L) 601 -0.01(-0.04 to 0.03) 0.64 595 0.00(-0.04 to 0.03) 0.93
LDL Cholesterol (mmol/L) 598 0.07(-0.07 to 0.21) 0.34 592 0.13(-0.01 to 0.27) 0.07
25(OH)D = 25-hydroxyvitamin D3; DXA = Dual X-ray Absorptiometry; BP = Blood Pressure; IMT = Intima-Media Thickness; aPWV = Aortic Pulse Wave
Velocity; HDL = High-density lipoprotein; LDL = Low-density lipoprotein
Model 1 adjusts for age and intervention status. Model 2, as in Model 1, plus further adjustment for lifestyle factors (standard of living index, occupation,
time spent in moderate or vigorous physical activity, smoking status), body fat and month of test. Results are based on linear mixed effect regression
models with robust standard errors to account for clustering at the household and village level, rounded to 2 decimal places.
* Model 2 excludes body fat
Ф Analysis of fasting glucose, insulin, HDL cholesterol and LDL cholesterol exclude participants who did not fast (n = 36)
†Logged values
doi:10.1371/journal.pone.0129468.t003
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from inaccurate measurement of body fat. This is supported by evidence from studies that also
had DXA-assessed body fat measurements [31–34].
Our study also corroborates the previous finding that people who do more moderate or vig-
orous physical activity have higher levels of serum vitamin D [35, 36]. This may simply reflect
greater exposure to UVB sunlight that such activity entails. Manual labour (including agricul-
tural work) is common in this rural setting and exercise for leisure is mostly in the form of out-
door sport. Similarly, female participants more commonly reported house-work which would
reduce their exposure to UVB sunlight; suggesting a possible explanation for their higher prev-
alence of vitamin D deficiency. A low level of serum vitamin Dmay still be considered a marker
of an unhealthy lifestyle, notably physical inactivity and obesity, rather than being causally re-
lated to cardiovascular disease risk [37, 38].
Strengths and limitations
The current study is one of the first observational studies to examine the association between
25(OH)D and CVD risk in a population exhibiting a very low prevalence of obesity or physical
inactivity. We also had a sufficiently large sample and access to high quality measurements of
the exposure of interest, a wide range of outcomes and key confounding variables. In particular,
our assessment of physical activity was very detailed. We lacked data on skin colour which may
Table 4. Association of serum vitamin D (25(OH)D)†with cardiovascular risk factors in a sample of young Indian females from the Andhra Pradesh
Children and Parents Study (n = 418)Ф; 2009–10.
Model 1 Model 2
N β coefﬁcient(95% CI) P N β coefﬁcient(95% CI) P
Outcomes—Physiological
Body Mass Index (kg/m2)* 418 -0.56(-1.22 to 0.11) 0.10 375 -0.61(-1.29 to 0.07) 0.08
Body Fat by DXA (%)* 380 -0.07(-0.11 to -0.02) 0.004 375 -0.05(-0.1 to -0.01) 0.02
Fat Mass Index (body fat kg/m2)* 380 -0.10(-0.17 to -0.02) 0.01 375 -0.09(-0.16 to-0.01) 0.02
Systolic BP (mmHg) 418 -1.49(-3.59 to 0.61) 0.16 375 -1.16(-3.44 to 1.12) 0.32
Diastolic BP (mmHg) 418 -2.60(-4.47 to -0.73) 0.01 375 -1.84(-3.74 to 0.06) 0.06
Carotid IMT (mm) 407 -0.01(-0.03 to 0.01) 0.18 364 -0.02(-0.04 to 0.00) 0.05
Aortic Augmentation Index (%) 408 -0.47(-3.41 to 2.47) 0.75 366 -1.31(-4.44 to 1.82) 0.41
aPWV (m s-1) 409 -0.09(-0.22 to 0.04) 0.16 374 -0.01(-0.15 to 0.13) 0.90
Outcomes—Biochemical
Insulin (mU/L)† 391 -0.14(-0.28 to -0.01) 0.04 356 -0.02(-0.16 to 0.12) 0.77
Fasting Glucose (mmol/L) 401 -0.01(-0.19 to 0.16) 0.87 365 0.08(-0.1 to 0.27) 0.38
Triglycerides (mg/dl)† 418 0.09(0.01 to 0.17) 0.03 375 0.04(-0.05 to 0.13) 0.36
Cholesterol (mmol/L) 418 0.16(-0.04 to 0.35) 0.12 375 0.10(-0.1 to 0.31) 0.31
HDL Cholesterol (mmol/L) 401 0.02(-0.03 to 0.07) 0.35 365 0.01(-0.04 to 0.06) 0.81
LDL Cholesterol (mmol/L) 401 0.07(-0.11 to 0.24) 0.46 365 0.06(-0.12 to 0.24) 0.50
25(OH)D = 25-hydroxyvitamin D3; DXA = Dual X-ray Absorptiometry; BP = Blood Pressure; IMT = Intima-Media Thickness; aPWV = Aortic Pulse Wave
Velocity; HDL = High-density lipoprotein; LDL = Low-density lipoprotein
Model 1 adjusts for age and intervention status. Model 2, as in Model 1, plus further adjustment for lifestyle factors (standard of living index, occupation,
time spent in moderate or vigorous physical activity, smoking status), body fat and month of test. Results are based on linear mixed effect regression
models with robust standard errors to account for clustering at the household and village level, rounded to 2 decimal places.
* Model 2 excludes body fat
Ф Analysis of fasting glucose, insulin, HDL cholesterol and LDL cholesterol exclude participants who did not fast (n = 36)
†Logged values
doi:10.1371/journal.pone.0129468.t004
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have been useful given the influence of skin pigmentation on synthesis of vitamin D [39]. The
participants were required to attend a clinic 1–2 hours away from home which limited our re-
sponse rate, particularly among females and those in full-time employment, and could have re-
sulted in selection bias, although no major baseline differences between participants and non-
participants were noted [12]. Our analyses were cross-sectional and therefore limit the ability
to infer causality. Our population displayed a relatively low risk of CVD therefore generalisa-
tion of our results to populations with higher risk of CVD may not be possible. Given the pro-
gressive emergence of CVD risk over the life-course, we cannot rule out the possible role of
serum vitamin D in CVD outcomes later in life, which may not have been captured in this
young population.
Public health implications
Our data, albeit limited to a particular population, do not support a causal role for vitamin D
in CVD risk. Given the inconsistent evidence on this subject to date, further research is needed
before vitamin D can be recommended for prevention of CVD. Maintenance of optimal vita-
min D levels may still be desirable for other outcomes (e.g. bone health[40]). For now, efforts
to prevent CVD should remain focussed on established risk factors, such as obesity and
physical inactivity.
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